Results 71 to 80 of about 2,386 (174)

Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis. [PDF]

CEN Case Rep, 2020
Nishizawa Y, Honda K, Aoyama Y, Hosoda Y, Tamura T, Horimoto A, Omae K, Higuchi C, Sakura H, Nitta K, Ogawa T.   +10 more
europepmc   +1 more source

Low-density lipoprotein apheresis shows a rapid response to proteinuria due to C3 glomerulonephritis: a case report and literature review

Renal Replacement Therapy
Background C3 glomerulonephritis (C3GN) is a rare renal disorder caused by dysregulation of the alternative complement pathway, resulting in abnormal C3 activation and deposition.
Hideki Matsumura, Yuko Fujii, Tomoko Tanaka, Maki Kagitani, Akira Ashida   +4 more
doaj   +1 more source

Advances in Lipid-Lowering Therapy for Homozygous Familial Hypercholesterolemia

罕见病研究
Homozygous familial hypercholesterolemia (HoFH) is an extremely rare and severe hereditary lipid metabolism disorder, characterized by markedly elevated levels of plasma low-density lipoprotein cholesterol (LDL-C), significantly increasing the risk of ...
LI Rui, TIAN Zhuang, ZHANG Shuyang
doaj   +1 more source

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection

Medical Devices: Evidence and Research, 2016
Ulrich Julius Lipidology and Center for Extracorporeal Therapy, Department for Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany Abstract: This review reports the current situation ...
Julius U
doaj  

Breaking barriers: Innovative therapies for managing homozygous familial hypercholesterolemia

Experimental and Molecular Pathology
Homozygous familial hypercholesterolemia (HoFH) is a rare autosomal recessive disorder characterized by variants in genes involved in the regulation of low-density lipoprotein cholesterol (LDL-C) metabolism.
Shuai-Jie Huang, Ping Huang, Nan-Nan Song, Xian-Hui Jia, Hong-Li Gao, Zhi-Yuan Lu, Xiao-Lan Wen   +6 more
doaj   +1 more source

Abstracts of the 18th SCWD Conference, 11‐13 December 2025 in Rome/Italy

JCSM Communications, Volume 9, Issue 1, January/June 2026.
wiley   +1 more source

Optimal lipid modification: the rationale for combination therapy

Vascular Health and Risk Management, 2005
James M Backes1, Cheryl A Gibson2, Patricia A Howard31Department of Pharmacy Practice, Lipid, Atherosclerosis, Metabolic and LDL Apheresis Center, University of Kansas Medical Center, Kansas City, KS, USA; 2Department of Internal Medicine, University of ...
James M Backes, Cheryl A Gibson, Patricia A Howard   +2 more
doaj  

Long-term Low-density Lipoprotein Apheresis in a Patient with Refractory Idiopathic Membranous Glomerulonephritis. [PDF]

Intern Med, 2017
Yabuuchi J, Suwabe T, Mizuno H, Ueno T, Hoshino J, Sekine A, Kawada M, Yamanouchi M, Hayami N, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K, Fujii T, Ohashi K, Ubara Y.   +15 more
europepmc   +1 more source

Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis. [PDF]

J Clin Apher, 2019
Szymanski JM, Waldman M, Conry-Cantilena C, West KA.   +3 more
europepmc   +1 more source

Efficacy of Low-Density Lipoprotein Apheresis in an Adult Case of Recurrent Focal Segmental Glomerulosclerosis Post-kidney Transplant. [PDF]

Cureus
Javanbakht A, Souter K, Armendariz T, Webb CB.   +3 more
europepmc   +1 more source